# AbbVie and iSTAR Medical form strategic alliance for glaucoma treatment

AbbVie and iSTAR Medical announced a strategic transaction to develop and commercialize iSTAR Medical's MINIject device, a minimally invasive glaucoma surgical device. The deal includes a $60 million upfront payment to iSTAR Medical, which will continue development and commercialization up to completion of the U.S. PMA study.

- Type: Partnership
- Announced: 2022-07-20
- Value: $60.0M
- Status: announced
- Products: MINIject glaucoma surgical device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AbbVie](https://endata.com/companies/29401.md) (partner)
- [iSTAR Medical](https://endata.com/companies/64264.md) (partner)

## Sources

- [news.abbvie.com](https://news.abbvie.com/2022-07-20-AbbVie-and-iSTAR-Medical-Announce-Strategic-Alliance-for-the-Treatment-of-Glaucoma), 2022-07-20: "Deal terms include a $60M upfront payment to iSTAR Medical"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.